AzTrials
AzTrials

Research institution

National Institute of Mental Health (NIMH) Clinical Trials

Studies where National Institute of Mental Health (NIMH) is the lead sponsor: what is enrolling now, by phase, condition and country.

367 registered studies

In numbers

Open to volunteers
45
Active
47
With results posted
49
All registered
367

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 45
  • Disruptive Behavior Disorders, Conduct Disorder

    Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool

    • Recruiting
    • Age: 8 to 13 years
    • Observational study
    • Lifestyle or therapy programme

    Background: Pediatric disruptive behavior disorders (DBDs) are characterized by severe irritability, anger, and temper outbursts. The primary way to treat children with DBDs is parent management training (PMT).

    Conditions
    Disruptive Behavior Disorders, Conduct Disorder, Oppositional Defiant Disorder, Attention-deficit/Hyperactivity Disorder
    Trial name
    NCT07764536
    Testing
    Psychotherapy
    Where
    United States
    Volunteers
    200 people
    Sponsor
    National Institute of Mental Health (NIMH)
  • Irritability, Disruptive Mood Dysregulation Disorder

    Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy

    • Recruiting
    • Age: 8 to 17 years
    • Observational study
    • Lifestyle or therapy programme

    Background: Irritability is defined as proneness to anger that may impair a person's ability to function. It is a common reason for why some children need mental health care.

    Conditions
    Irritability, Disruptive Mood Dysregulation Disorder, Oppositional Defiant Disorder, Attention Deficit Hyperactivity Disorder
    Trial name
    NCT07640802
    Testing
    Psychotherapy
    Where
    United States
    Volunteers
    410 people
    Sponsor
    National Institute of Mental Health (NIMH)
  • Alzheimer s Disease, Mild Cognitive Impairment

    PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

    • Recruiting
    • Age: 50 to 100 years
    • Phase 1

    Background: About 5 million adults in the United States have age-related brain disorders. These include Alzheimer disease (AD), mild cognitive impairment (MCI), and other dementias.

    Conditions
    Alzheimer s Disease, Mild Cognitive Impairment, Healthy
    Trial name
    NCT07169630
    Testing
    18F-PF974, 18F-florbetaben
    Where
    United States
    Volunteers
    90 people, healthy volunteers welcome
    Sponsor
    National Institute of Mental Health (NIMH)
  • Irritability

    Psychological Treatments for Youth With Severe Irritability.

    • Recruiting
    • Age: 8 to 17 years
    • Observational study

    Background: When children have severe irritability and temper outbursts, they can be so cranky or angry that it leads to problems at home, in school, and with friends.

    Trial name
    NCT02531893
    Where
    United States
    Volunteers
    200 people
    Sponsor
    National Institute of Mental Health (NIMH)
  • Healthy

    First-in-Human Evaluation of [11C]JMJ-129-d2 for PDE4D Imaging in Healthy Volunteers

    • Recruiting
    • Age: 18 to 105 years
    • Phase 1

    Background: PDE4D is a protein found in the brain. It helps control chemical signals that affect mood, memory, and thinking. Problems with PDE4D may play a role in depression and Alzheimer's disease.

    Trial name
    NCT07853781
    Testing
    [11C]JMJ-129-d2
    Where
    United States
    Volunteers
    40 people, healthy volunteers welcome
    Sponsor
    National Institute of Mental Health (NIMH)
  • Brain Mapping, Healthy Volunteer

    Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites in Human Brain and Muscle

    • Recruiting
    • Age: 18 to 65 years

    Background: Magnetic resonance imaging (MRI) is a widely used scanning technique to obtain images of the human body and evaluate activity in the brain.

    Trial name
    NCT01266577
    Testing
    NSR MAGNETOM 7T, 1Tx x 32Rx Head Coil
    Where
    United States
    Volunteers
    300 people, healthy volunteers welcome
    Sponsor
    National Institute of Mental Health (NIMH)
  • Psychiatric Disorders, Anxiety Disorders

    Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety

    • Recruiting
    • Age: 8 to 17 years
    • Phase 2
    • Lifestyle or therapy programme

    Background: Anxiety disorders are becoming more common among children and teenagers. Anxiety can lead to long-term physical and mental problems, such as depression.

    Trial name
    NCT06595953
    Testing
    Gaze-Contingent Music Reward Therapy
    Where
    United States
    Volunteers
    150 people
    Sponsor
    National Institute of Mental Health (NIMH)
  • Healthy Volunteer

    Studies of Blood Flow to the Brain During Thought

    • Recruiting
    • Age: 18 to 65 years
    • Observational study

    The purpose of this study is to use brain imaging technology to measure changes in blood flow to areas in the brain as individuals perform intellectual tasks.

    Trial name
    NCT00001360
    Where
    United States
    Volunteers
    4,100 people, healthy volunteers welcome
    Sponsor
    National Institute of Mental Health (NIMH)
  • Anxiety Disorders, Major Depressive Disorder

    Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

    • Recruiting
    • Age: 8 to 65 years
    • Phase 2
    • Lifestyle or therapy programme

    Study Description: This study examines relations between neurocognitive and clinical features of pediatric anxiety disorders. The study uses neuro-cognitive tasks, functional magnetic resonance imaging (fMRI), as well as magneto…

    Trial name
    NCT00018057
    Testing
    Attention Bias Modification Training, Fluoxetine, Cognitive Behavioral Therapy
    Where
    2 sites in United States
    Volunteers
    3,500 people, healthy volunteers welcome
    Sponsor
    National Institute of Mental Health (NIMH)
  • Mood Disorders, Anxiety Disorders

    Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders

    • Recruiting
    • Age: 18 to 65 years
    • Observational study
    • Medical device

    This study is intended to help develop new MRI imaging techniques for studying mood and anxiety disorders. Researchers believe that depression and anxiety disorders may cause structural and functional changes in the brain.

    Trial name
    NCT00397111
    Testing
    7T Magnetic Resonance Imaging scanner
    Where
    United States
    Volunteers
    390 people, healthy volunteers welcome
    Sponsor
    National Institute of Mental Health (NIMH)

Completed, with results posted

All 33
  • Postpartum Depression

    The Role of Hormones in Postpartum Mood Disorders

    • Completed
    • Age: 18 to 50 years
    • Phase 2
    • Results posted

    The present protocol is designed to create a "scaled-down" hormonal milieu of pregnancy and the puerperium in order to determine whether it is the abrupt withdrawal of gonadal steroids or the prolonged exposure to gonadal…

    Trial name
    NCT00001481
    Testing
    Estradiol, Progesterone, leuprolide acetate
    Where
    United States
    Volunteers
    74 people
    Sponsor
    National Institute of Mental Health (NIMH)
  • Perimenopause-Related Depression

    Estrogen Receptor Beta and Mood

    • Completed
    • Age: 45 to 65 years
    • Phase 2
    • Results posted

    Background: Our previous studies have found that women who had depression during the perimenopause may have mood symptoms again if they stop estrogen therapy.

    Trial name
    NCT03689543
    Testing
    Estradiol, ER Beta Agonist, Provera
    Where
    United States
    Volunteers
    74 people
    Sponsor
    National Institute of Mental Health (NIMH)
    Can I take part? NCT03689543
  • Major Depressive Disorder

    Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine

    • Completed
    • Age: 18 to 65 years
    • Phase 1
    • Results posted

    A 6-cohort single ascending dose (SAD) study will be conducted in healthy volunteers utilizing a slow-infusion intravenous (IV) route of administration.

    Trial name
    NCT04711005
    Testing
    (2R,6R)-Hydroxynorketamine hydrochloride
    Where
    United States
    Volunteers
    74 people, healthy volunteers welcome
    Sponsor
    National Institute of Mental Health (NIMH)
  • Anxiety, Healthy Volunteers

    Identifying Decision Making Parameters in Healthy Volunteers and Anxiety Patients

    • Completed
    • Age: 18 to 50 years
    • Medical device
    • Results posted

    Background: Research has shown that anxiety affects more than feelings. It also affects behavior. Researchers want to learn how the brain and body respond to unexpected threats.

    Trial name
    NCT05092971
    Testing
    Shock or startle device
    Where
    United States
    Volunteers
    51 people, healthy volunteers welcome
    Sponsor
    National Institute of Mental Health (NIMH)
    Can I take part? NCT05092971
  • Anxiety Disorders, Fear

    Brain Imaging Changes in Fear and Anxiety

    • Completed
    • Age: 18 to 50 years
    • Medical device
    • Results posted

    The purpose of this study is to use brain imaging technology to investigate brain changes in people exposed to predictable versus unpredictable unpleasant stimuli.

    Trial name
    NCT00047853
    Testing
    Shock device, Acoustic startle
    Where
    United States
    Volunteers
    1,080 people, healthy volunteers welcome
    Sponsor
    National Institute of Mental Health (NIMH)
    Can I take part? NCT00047853

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in